﻿<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd"[]>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Science and Education Publishing</PublisherName>
      <JournalTitle>American Journal of Clinical Medicine Research</JournalTitle>
      <Issn>2328-403X</Issn>
      <Volume>2</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="epublish">
        <Year>2014</Year>
        <Month>02</Month>
        <Day>09</Day>
      </PubDate>
    </Journal>
    <ArticleTitle>Donor Selection in Allogeneic Stem Cell Transplantation</ArticleTitle>
    <FirstPage>32</FirstPage>
    <LastPage>35</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mehmet Ali</FirstName>
        <LastName>ERKURT</LastName>
      </Author>
      <Author>
        <FirstName>Ilhami</FirstName>
        <LastName>BERBER</LastName>
        <Affiliation>Department of Hematology, Faculty of Medicine, Inonu University, Malatya, Turkey</Affiliation>
      </Author>
      <Author>
        <FirstName>Irfan</FirstName>
        <LastName>KUKU</LastName>
      </Author>
      <Author>
        <FirstName>Emin</FirstName>
        <LastName>KAYA</LastName>
      </Author>
      <Author>
        <FirstName>Ilknur</FirstName>
        <LastName>NIZAM</LastName>
      </Author>
    </AuthorList>
    <ArticleIdList>
      <ArticleId IdType="pii">AJCMR2014218</ArticleId>
      <ArticleId IdType="doi">10.12691/ajcmr-2-1-8</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>07</Day>
      </PubDate>
      <PubDate PubStatus="revised">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>26</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2014</Year>
        <Month>02</Month>
        <Day>09</Day>
      </PubDate>
    </History>
    <Abstract>Allogeneic hematopoietic stem cell transplant is safe and  curative treatment modality for many hematologic diseases. Expanding alternative donor options such as haploidentical hematopoietic stem cell transplantation and umbilical cord blood, taken together with enhanced outcomes of matched unrelated donors, has resulted in a advisable donor for most patients with an hematopoietic stem cell transplantation indication. This review article provides improved patient selection, offers hope for decreasing relapse and improving outcomes for in patients applied allogeneic hematopoietic stem cell transplant.</Abstract>
  </Article>
</ArticleSet>